abs425.txt	background		epidemiologic	evidence	for	a	serum	cholesterol-prostate	cancer	linkis	mixed		prostate-specific	antigen	(psa)	is	positively	correlated	withcholesterol		potentially	increasing	psa-driven	biopsy	recommendations	in	men	withhigh	cholesterol		though	biopsy	compliance	may	be	lower	in	men	with	comorbidconditions		these	potential	biases	may	affect	psa-driven	biopsy	rates	andsubsequent	prostate	cancer	detection	in	men	with	high	serum	cholesterol		ourobjective	was	to	test	the	association	between	serum	cholesterol	and	prostatecancer	risk	in	men	receiving	psa	independent		study-mandated	prostate	biopsies	methods		we	conducted	a	post	hoc	analysis	of	data	from	4974	non-statin	users	inreduce		a	randomized	trial	in	men	with	elevated	psa	and	a	negative	baselinebiopsy		men	underwent	2-	and	4-year	trial-mandated	prostate	biopsies	associations	between	baseline	serum	levels	of	total	cholesterol		low-densitylipoprotein	(ldl)		high-density	lipoprotein	(hdl)	and	prostate	cancer	risk	overall	and	by	gleason	grade	(<7	vs		â‰¥7)		were	examined	using	multivariablelogistic	regression	results		high	total	serum	cholesterol	was	associated	with	an	increased	risk	ofhigh-grade	prostate	cancer	diagnosis	(or	per	10	mg/dl	1	05		95%	ci	1	00-1	09	p	=	0	048)		but	cholesterol	was	unrelated	to	either	overall	or	low-grade	prostatecancer	risk	(p-values	>0	185)		there	was	no	association	between	serum	ldl	andoverall		low-	or	high-grade	prostate	cancer	risk	(p-values	>0	137)		in	contrast	elevated	serum	hdl	was	associated	with	increased	risk	of	both	overall	(or	per10	mg/dl	1	08		95%	ci	1	01-1	16		p	=	0	033)	and	high-grade	prostate	cancer	(orper	10	mg/dl	1	14		95%	ci	1	01-1	28		p	=	0	034)	conclusions		in	reduce		where	all	men	received	psa	independent		trial-mandatedbiopsies	thus	ensuring	complete	prostate	cancer	ascertainment		high	total	serumcholesterol	and	high	hdl	were	associated	with	increased	risk	of	high-gradeprostate	cancer		supporting	a	cholesterol-prostate	cancer	link	
